CES1 and SLC6A2 Genetic Variants As Predictors of Response To Methylphenidate in Autism Spectrum Disorders

Marta H Hernandez1,2 *, Valentin Bote3 *, Alexandre Serra-LLovich,1 Marc Cendros,1,4 Juliana Salazar,5 Conxita Mestres,2 Silvina Guijarro,3 Aida Alvarez,3 Cristina Lamborena,3 Iria Mendez,3 Bernardo Sanchez,3 Amaia Hervas,3 Maria J Arranz1,2 1Research Laboratory Unit, Fundació Docènc...

Full description

Bibliographic Details

Published in:	Pharmacogenomics and Personalized Medicine
Main Authors:	Hernandez MH, Bote V, Serra-LLovich A, Cendros M, Salazar J, Mestres C, Guijarro S, Alvarez A, Lamborena C, Mendez I, Sanchez B, Hervas A, Arranz MJ
Format:	Article
Language:	English
Published:	Dove Medical Press 2022-11-01
Subjects:	ces1 slc6a2 autistic spectrum disorders asd methylphenidate attention deficit hyperactivity disorders adhd.
Online Access:	https://www.dovepress.com/ces1-and-slc6a2-genetic-variants-as-predictors-of-response-to-methylph-peer-reviewed-fulltext-article-PGPM